Amedisys Inc

Ownership Transactions Reported by 20 Insiders

Symbol
AMED on Nasdaq
Location
3854 American Way, Suite A, Baton Rouge, LA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Amedisys Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
B. Kusserow Paul Director $33.1M May 3, 2024
Richard M. Ashworth President and CEO, Director $10.6M Feb 16, 2024
Scott G. Ginn Evp, Cfo & Coo $7.68M Jun 26, 2024
Christopher Gerard President & COO $4.01M Feb 17, 2022
Nick Muscato Chief Strategy Officer $3.03M Nov 5, 2024
Sharon Brunecz Chief Human Resources Officer $2.48M Feb 17, 2022
Michael Paul North Chief Information Officer $2.14M Feb 16, 2024
Bruce D. Perkins Director $2.1M May 3, 2024
Jennifer G. Griffin Chief Legal Officer $1.74M Nov 4, 2024
David L. Kemmerly Chief Legal & Government Affairs Officer $1.6M Mar 29, 2022
Denise M. Bohnert Chief Compliance Officer $1.5M Feb 16, 2024
Julie D. Klapstein Director $1.34M May 3, 2024
Adam Y. Holton Chief People Officer $1.02M Feb 16, 2024
Richard A. Lechleiter Director $908K Nov 30, 2021
Allyson Guidroz Chief Accounting Officer $870K Jul 31, 2024
Vickie L. Capps Director $762K May 3, 2024
Teresa L. Kline Director $762K May 3, 2024
Jeffrey A. Rideout Director $716K May 3, 2024
Molly Joel Coye Director $668K May 3, 2024
Ivanetta Davis Samuels Director $544K May 3, 2024

Recent Insider Transactions by Companies or Individuals for Amedisys Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.